Megaloblastic anaemia and pancytopenia secondary to prophylactic cotrimoxazole therapy

Journal of Paediatrics and Child Health

Volumn 33, Issue 2, 1997, Pages 166-167

  Tapp, H ^a,b   Savarirayan, R ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

cotrimoxazole prophylaxis; folate antagonism; megaloblastic anaemia; pancytopenia

Indexed keywords

COTRIMOXAZOLE; CYANOCOBALAMIN; FERRITIN; FOLIC ACID; IRON; NALIDIXIC ACID; TRANSFERRIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; CHILD; ESCHERICHIA COLI; FOLIC ACID DEFICIENCY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MEGALOBLASTIC ANEMIA; ORAL DRUG ADMINISTRATION; PANCYTOPENIA; PRIORITY JOURNAL; URINARY TRACT INFECTION; VESICOURETERAL REFLUX;

EID: 0030907027     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.1997.tb01022.x     Document Type: Article

References (8)

1. Hamblin TJ. Cotrimoxazole and the blood. Lancet. 1973; 2: 1153-4.
2. Fleming AF. Cotrimoxazle and the blood. Lancet. 1974; 2: 284-5.
3. Meyler's Side Effects of Drugs: An encyclopaedia of adverse reactions and interactions. Twelfth Edition, Elsevier, Amsterdam, 1992.
4. Dawborn JK. The prolonged use of trimethoprim/sulphonamide in urinary infection. Med. J. Aust. 1973: (Suppl 1): 52-6.
5. Australian Drug Evaluation Committee: Cotrimoxazole induced blood dyscrasias in paediatric. AGPS, Australian Department of Human Services and Health, Canberra, 1994.
6. Davis RE. Trimethoprim/suphamethoxazole effect on folate metabolism. Med. J. Aust. 1973:(Suppl 1): 30-3.
7. Asmar BI. Hematologic abnormalities after oral trimethoprim-sulfamethoxazole therapy in children. Am. J. Dis. Child. 1981; 135: 1100-3.
8. Girdwood RH. Trimethoprim/sulphamethoxazole: Long term therapy and folate levels. Med. J. Aust. 1973: (Suppl 1): 34-6.